Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSE:HYH
CUSIPN/A
Phone678-425-9273
Debt
Debt-to-Equity Ratio0.43
Current Ratio3.22
Quick Ratio2.96
Price-To-Earnings
Trailing P/E Ratio25.72
Forward P/E Ratio34.18
P/E Growth3.81
Sales & Book Value
Annual Sales$611.60 million
Price / Sales4.65
Cash Flow$1.2532 per share
Price / Cash48.27
Book Value$25.95 per share
Price / Book2.33
Profitability
EPS (Most Recent Fiscal Year)$2.35
Net Income$79.30 million
Net Margins7.72%
Return on Equity7.90%
Return on Assets4.38%
Miscellaneous
Employees13,000
Outstanding Shares47,020,000
Halyard Health (NYSE:HYH) Frequently Asked Questions
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health (NYSE:HYH) issued its earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.76 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.17 by $0.59. The medical instruments supplier earned $156.40 million during the quarter, compared to the consensus estimate of $155.08 million. Halyard Health had a return on equity of 7.90% and a net margin of 7.72%. The business's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share. View Halyard Health's Earnings History.
What guidance has Halyard Health issued on next quarter's earnings?
Halyard Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus estimate of $1.26.
What price target have analysts set for HYH?
5 brokers have issued 1 year target prices for Halyard Health's stock. Their forecasts range from $50.00 to $62.00. On average, they expect Halyard Health's stock price to reach $55.50 in the next year. View Analyst Ratings for Halyard Health.
Who are some of Halyard Health's key competitors?
Some companies that are related to Halyard Health include WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Invacare (IVC), Consort Medical (CSRMY), Sientra (SIEN), RTI Surgical (RTIX), Lakeland Industries (LAKE), Histogenics (HSGX), ConforMIS (CFMS), Rewalk Robotics (RWLK), NanoVibronix (NAOV) and Precision Therapeutics (AIPT).
Who are Halyard Health's key executives?
Halyard Health's management team includes the folowing people:
- Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
- Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
- Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
- Mr. Joseph F. Woody, CEO & Director (Age 52)
- Mr. Renato Negro, VP, Controller & Chief Accounting Officer
Has Halyard Health been receiving favorable news coverage?
Headlines about HYH stock have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Halyard Health earned a news sentiment score of 0.21 on Accern's scale. They also assigned news coverage about the medical instruments supplier an impact score of 46.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
Who are Halyard Health's major shareholders?
Halyard Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.62%), Dimensional Fund Advisors LP (7.28%), Paradice Investment Management LLC (3.30%), Northern Trust Corp (3.23%), Champlain Investment Partners LLC (1.60%) and Prudential Financial Inc. (1.03%). View Institutional Ownership Trends for Halyard Health.
Which institutional investors are selling Halyard Health stock?
HYH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Prudential Financial Inc., Chicago Equity Partners LLC, Schwab Charles Investment Management Inc., Wells Fargo & Company MN, Spark Investment Management LLC, Citigroup Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Halyard Health.
Which institutional investors are buying Halyard Health stock?
HYH stock was purchased by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Select Equity Group L.P., Great West Life Assurance Co. Can, New York State Common Retirement Fund, Lord Abbett & CO. LLC, Millennium Management LLC, BlackRock Inc. and Great Lakes Advisors LLC. View Insider Buying and Selling for Halyard Health.
How do I buy shares of Halyard Health?
Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Halyard Health's stock price today?
One share of HYH stock can currently be purchased for approximately $60.49.
How big of a company is Halyard Health?
Halyard Health has a market capitalization of $2.82 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.
How can I contact Halyard Health?
Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]
MarketBeat Community Rating for Halyard Health (HYH)
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
